196 related articles for article (PubMed ID: 30325864)
1. A Prospective Study to Establish a New-Onset Diabetes Cohort: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.
Maitra A; Sharma A; Brand RE; Van Den Eeden SK; Fisher WE; Hart PA; Hughes SJ; Mather KJ; Pandol SJ; Park WG; Feng Z; Serrano J; Rinaudo JAS; Srivastava S; Chari ST;
Pancreas; 2018; 47(10):1244-1248. PubMed ID: 30325864
[TBL] [Abstract][Full Text] [Related]
2. Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer: From Concept to Reality.
Serrano J; Andersen DK; Forsmark CE; Pandol SJ; Feng Z; Srivastava S; Rinaudo JAS;
Pancreas; 2018; 47(10):1208-1212. PubMed ID: 30325859
[TBL] [Abstract][Full Text] [Related]
3. The association of new-onset diabetes with subsequent diagnosis of pancreatic cancer-novel use of a large administrative database.
White MJ; Sheka AC; LaRocca CJ; Irey RL; Ma S; Wirth KM; Benner A; Denbo JW; Jensen EH; Ankeny JS; Ikramuddin S; Tuttle TM; Hui JYC; Marmor S
J Public Health (Oxf); 2023 Jun; 45(2):e266-e274. PubMed ID: 36321614
[TBL] [Abstract][Full Text] [Related]
4. Consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer: achievements and future directions.
Pandol SJ; Forsmark CE;
Curr Opin Gastroenterol; 2021 Sep; 37(5):486-490. PubMed ID: 34156036
[TBL] [Abstract][Full Text] [Related]
5. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies: Rationale and Study Design for PROCEED From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.
Yadav D; Park WG; Fogel EL; Li L; Chari ST; Feng Z; Fisher WE; Forsmark CE; Jeon CY; Habtezion A; Hart PA; Hughes SJ; Othman MO; Rinaudo JAS; Pandol SJ; Tirkes T; Serrano J; Srivastava S; Van Den Eeden SK; Whitcomb DC; Topazian M; Conwell DL;
Pancreas; 2018; 47(10):1229-1238. PubMed ID: 30325862
[TBL] [Abstract][Full Text] [Related]
6. Standard Operating Procedures for Biospecimen Collection, Processing, and Storage: From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.
Fisher WE; Cruz-Monserrate Z; McElhany AL; Lesinski GB; Hart PA; Ghosh R; Van Buren G; Fishman DS; Rinaudo JAS; Serrano J; Srivastava S; Mace T; Topazian M; Feng Z; Yadav D; Pandol SJ; Hughes SJ; Liu RY; Lu E; Orr R; Whitcomb DC; Abouhamze AS; Steen H; Sellers ZM; Troendle DM; Uc A; Lowe ME; Conwell DL;
Pancreas; 2018; 47(10):1213-1221. PubMed ID: 30325860
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Mixed Meal Test for Diagnosis and Characterization of PancrEaTogEniC DiabeTes Secondary to Pancreatic Cancer and Chronic Pancreatitis: Rationale and Methodology for the DETECT Study From the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.
Hart PA; Andersen DK; Mather KJ; Castonguay AC; Bajaj M; Bellin MD; Bradley D; Contreras N; Habtezion A; Korc M; Kudva Y; Petrov MS; Whitcomb DC; Yadav D; Yuan Y; Rinaudo JAS; Srivastava S; Serrano J; Goodarzi MO;
Pancreas; 2018; 47(10):1239-1243. PubMed ID: 30325863
[TBL] [Abstract][Full Text] [Related]
8. New Onset of DiabetEs in aSsociation with pancreatic ductal adenocarcinoma (NODES Trial): protocol of a prospective, multicentre observational trial.
Illés D; Ivány E; Holzinger G; Kosár K; Adam MG; Kamlage B; Zsóri G; Tajti M; Svébis MM; Horváth V; Oláh I; Márta K; Váncsa S; Zádori N; Szentesi A; Czakó B; Hegyi P; Czakó L
BMJ Open; 2020 Nov; 10(11):e037267. PubMed ID: 33444177
[TBL] [Abstract][Full Text] [Related]
9. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
[TBL] [Abstract][Full Text] [Related]
10. Risk of pancreatic cancer in people with new-onset diabetes: A Danish nationwide population-based cohort study.
Jensen MH; Cichosz SL; Hejlesen O; Henriksen SD; Drewes AM; Olesen SS
Pancreatology; 2023 Sep; 23(6):642-649. PubMed ID: 37422338
[TBL] [Abstract][Full Text] [Related]
11. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
[TBL] [Abstract][Full Text] [Related]
12. Decreased Serum Thrombospondin-1 Levels in Pancreatic Cancer Patients Up to 24 Months Prior to Clinical Diagnosis: Association with Diabetes Mellitus.
Jenkinson C; Elliott VL; Evans A; Oldfield L; Jenkins RE; O'Brien DP; Apostolidou S; Gentry-Maharaj A; Fourkala EO; Jacobs IJ; Menon U; Cox T; Campbell F; Pereira SP; Tuveson DA; Park BK; Greenhalf W; Sutton R; Timms JF; Neoptolemos JP; Costello E
Clin Cancer Res; 2016 Apr; 22(7):1734-1743. PubMed ID: 26573598
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.
Rychlíková J; Vecka M; Jáchymová M; Macášek J; Hrabák P; Zeman M; Vávrová L; Řoupal J; Krechler T; Ák A
Cancer Biomark; 2016 Jun; 17(1):55-65. PubMed ID: 27314293
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic ductal adenocarcinoma presenting with acute and chronic pancreatitis as initial presentation: is prognosis better? A comparison study.
Thorat A; Huang WH; Yeh TS; Jan YY; Hwang TL
Hepatogastroenterology; 2014 Oct; 61(135):2110-6. PubMed ID: 25713917
[TBL] [Abstract][Full Text] [Related]
15. Discriminating patients with early-stage pancreatic cancer or chronic pancreatitis using serum electrospray mass profiling.
Hocker JR; Postier RG; Li M; Lerner MR; Lightfoot SA; Peyton MD; Deb SJ; Baker CM; Williams TL; Hanas RJ; Stowell DE; Lander TJ; Brackett DJ; Hanas JS
Cancer Lett; 2015 Apr; 359(2):314-24. PubMed ID: 25637792
[TBL] [Abstract][Full Text] [Related]
16. Blood-based Migration Signature Biomarker Panel Discriminates Early Stage New Onset Diabetes related Pancreatic Ductal Adenocarcinoma from Type 2 Diabetes.
Balasenthil S; Liu S; Dai J; Bamlet WR; Petersen G; Chari ST; Maitra A; Chen N; Sen S; McNeill Killary A
Clin Chim Acta; 2023 Nov; 551():117567. PubMed ID: 37774897
[TBL] [Abstract][Full Text] [Related]
17. Pancreatitis-diabetes-pancreatic cancer: summary of an NIDDK-NCI workshop.
Andersen DK; Andren-Sandberg Å; Duell EJ; Goggins M; Korc M; Petersen GM; Smith JP; Whitcomb DC
Pancreas; 2013 Nov; 42(8):1227-37. PubMed ID: 24152948
[TBL] [Abstract][Full Text] [Related]
18. Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma.
Gao W; Zhou Y; Li Q; Zhou Q; Tan L; Song Y; Zhao X; Yu M; Zheng S; Ye H; Zeng B; Lin Q; Zhou J; Liu Y; Huang H; Zhang H; Hu X; Li Z; Dai X; Chen R
Diabetologia; 2015 Apr; 58(4):835-44. PubMed ID: 25636208
[TBL] [Abstract][Full Text] [Related]
19. Informative Patterns of Health-Care Utilization Prior to the Diagnosis of Pancreatic Ductal Adenocarcinoma.
Coté GA; Xu H; Easler JJ; Imler TD; Teal E; Sherman S; Korc M
Am J Epidemiol; 2017 Oct; 186(8):944-951. PubMed ID: 28541521
[TBL] [Abstract][Full Text] [Related]
20. Distinct pathophysiological cytokine profiles for discrimination between autoimmune pancreatitis, chronic pancreatitis, and pancreatic ductal adenocarcinoma.
Ghassem-Zadeh S; Gaida MM; Szanyi S; Acha-Orbea H; Frossard JL; Hinz U; Hackert T; Strobel O; Felix K
J Transl Med; 2017 Jun; 15(1):126. PubMed ID: 28578701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
